Choosing an adipose tissue banking provider is a decision that deserves the same diligence you would apply to any significant cash-pay health investment, because the regulatory compliance of the laboratory, the training of the provider performing the harvest, and the transparency of the banking program all directly affect what you actually get for your investment. The adipose tissue banking space includes both fully compliant, FDA-registered services and a range of offerings that blur the line between banking and unregulated treatment claims, which makes the evaluation framework especially important. This guide gives you seven specific criteria to apply when evaluating any banking service, the questions to ask before you commit, and the red flags that should stop a conversation immediately.
TLDR: Evaluate any banking service on seven criteria: FDA-registered processing laboratory, no treatment claims, trained and credentialed harvest providers, viability certification, transparent pricing, clear storage terms and cell ownership, and documented chain of custody. Ask for evidence on each criterion before committing. Red flags include treatment claims, no published lab credentials, and pricing packages that bundle banking with therapeutic services that have no FDA approval.
Important Disclaimer: This post provides a general evaluation framework for banking services. Save My Fat is one option among services in this space. This post does not constitute an endorsement or critique of any specific competitor. Patients should conduct their own due diligence on any banking service before making a financial commitment. All content is for educational purposes only and does not constitute medical or financial advice.
The adipose tissue banking market is not mature enough to have universal industry standards, which means the quality and compliance of services varies significantly from one provider to the next. A patient who chooses a banking service based on marketing alone may pay a significant sum for cells stored in conditions that are not FDA-compliant, processed by a laboratory with no published credentials, by a provider with no specific training in the harvest technique. The evaluation framework in this post is designed to protect you from that outcome by giving you specific criteria that any well-informed patient should apply to any banking service under consideration.
The seven criteria below are the questions any well-informed patient should ask before committing to any banking service, including Save My Fat. Use them as your evaluation checklist, and treat unsatisfactory answers as important information regardless of how compelling the rest of the marketing has been.
The Seven Criteria for Evaluating Any Banking Service
Criterion 1: Is the Processing Laboratory FDA-Registered?
The laboratory that processes and stores your cells must be registered with the FDA as a Human Cells, Tissues, and Cellular and Tissue-Based Products establishment under 21 CFR Part 1271. This registration is a legal requirement for any laboratory providing tissue banking services in the United States, not an optional credential or a marketing badge. The FDA’s tissue products page is the primary federal reference for what the registration covers and why it matters.
How to verify. Ask the banking service for the name of their processing laboratory and search the FDA’s tissue establishment registry directly. If the laboratory is not listed, the banking service is not operating under the required regulatory framework, and that answer is disqualifying on its own. Save My Fat’s overview of 21 CFR Part 1271 covers the regulatory framework in patient-appropriate depth for anyone who wants to understand what FDA registration actually entails.
Save My Fat: L2 Bio is an FDA-registered tissue establishment operating under the Section 361 HCT/P framework.
Criterion 2: Does the Service Make Treatment Claims?
A compliant banking service makes no treatment claims. It does not claim to treat, cure, or prevent any disease. It does not describe the banked cells as a therapy. It describes itself as tissue preservation for potential future use in FDA-regulated pathways as they become available. This distinction is not cosmetic. It is the line between a compliant Section 361 HCT/P service at 21 CFR Part 1271 and a service operating outside that framework.
Any service that claims banking will treat your arthritis, reverse aging, or cure a specific condition is making claims that go beyond what a Section 361 HCT/P banking service is permitted to make. That should be a complete disqualifier. Save My Fat’s resources on banking vs. stem cell treatment clinics and fake stem cell clinic red flags cover the pattern in more depth, and the distinction is consistent enough that it can be spotted in minutes of reviewing a service’s marketing materials.
Save My Fat: no treatment claims are made. The service is described as tissue preservation throughout.
Criterion 3: Are the Harvest Providers Trained and Credentialed?
The physician performing your harvest should be specifically trained in the Save My Fat or equivalent harvest protocol and should hold appropriate medical licensure for performing outpatient procedures in their state. The questions worth asking specifically are what training the provider completed for the banking harvest, whether the provider performing the harvest is a licensed physician, and whether the procedure is being performed in a licensed clinical facility rather than a wellness center or non-clinical setting.
A harvest performed by an unlicensed provider or in a non-clinical setting is both a safety concern and a regulatory red flag. The regulatory framework at 21 CFR Part 1271 applies to compliant banking operations, and non-clinical settings typically cannot meet the chain-of-custody and procedural standards the framework requires. Save My Fat’s provider program page covers the partner network structure and the credential framework that applies across the partner base.
Save My Fat: all partner providers are trained, licensed physicians operating in their existing clinical practice settings.
Criterion 4: Do You Receive a Viability Certificate?
After processing, you should receive a documented viability certificate that specifies the total cell yield from your harvest, the post-processing viability percentage, the vial count, and the storage confirmation. This document is your evidence of what you actually banked and its quality at the time of cryopreservation. The published MSC biology literature supports why viability documentation matters for any future clinical application, and Save My Fat’s overview of cryopreservation viability covers what the data points on the certificate actually represent.
A banking service that does not provide viability documentation is asking you to take the quality of your cells on faith. That is not acceptable for a service of this cost and long-term importance, because without documentation you have no record of what was banked and no baseline against which to assess the cells if they are ever accessed in the future.
Save My Fat: every patient receives a viability certificate from L2 Bio documenting the specific yield, viability percentage, and vial count for their banking event.
Criterion 5: Is Pricing Transparent and Fully Itemized?
The full cost of banking should be disclosed before you commit. This includes the initial package price, what is included in that price, annual storage fees, any additional fees for vial release or shipping when cells are accessed, and whether pricing can change over the storage term. An itemized written breakdown, not a verbal or summary quote, is the appropriate documentation to receive before signing.
Avoid any service that does not provide a complete written pricing breakdown before you sign. Unexpected fees discovered after banking significantly reduce the value of the investment, and a service that is reluctant to provide full pricing upfront is signaling that the full cost may be higher than the advertised package suggests. Save My Fat’s resource on how to compare banking services covers the pricing comparison framework in more depth, and current Save My Fat package pricing is published directly on the Save My Fat website at savemyfat.com/pricing.
Save My Fat: current pricing is published with itemized package details, and the pricing page is linked directly from the main navigation of the Save My Fat website.
Criterion 6: Are Storage Terms and Cell Ownership Clear?
Before banking, confirm in writing who owns the banked cells (the answer must be you, the patient), what happens to your cells if the banking service or laboratory closes, whether there are contractual protections for long-term storage continuity, and the conditions under which your cells could be destroyed or forfeited. These terms should be explicit in the patient agreement rather than mentioned only in verbal representations.
These are not hypothetical questions. Banking services do close. Laboratories do change ownership. Your cells should be protected by clear contractual terms regardless of what happens to the business providing the service, and any banking service that resists addressing these questions directly is signaling that the answers may not favor the patient. Save My Fat’s resources on questions to ask before banking and the complete guide to banking both cover the ownership and continuity considerations in more depth.
Save My Fat: patient ownership and storage continuity terms are documented in the patient agreement, which is available for review before signing.
Criterion 7: Is the Chain of Custody Documented?
The path from your harvest to your stored vials should be documented at every step: harvest packaging, shipping manifest, laboratory receipt, processing record, and storage confirmation. Chain-of-custody documentation is both a regulatory requirement under the 21 CFR Part 1271 framework and a quality assurance standard that protects you. It is your evidence that the cells in storage are actually the cells removed from your body rather than a mislabeled or unverified substitute.
Ask what chain-of-custody documentation you will receive, and at what stages. A service that cannot describe the chain-of-custody process clearly is either not operating under the compliant framework or has not implemented the documentation that framework requires. Save My Fat’s overview of how banking works covers the chain of custody from harvest through storage in patient-facing depth.
Save My Fat: chain-of-custody documentation is generated at each stage from harvest through storage, under the standardized Save My Fat and L2 Bio protocol.
The Evaluation Summary Table
| Criterion | What to Ask | Red Flag |
|---|---|---|
| FDA-registered laboratory | Name of processing lab, then verify on FDA registry | Lab name not on FDA registry |
| No treatment claims | Review all marketing materials for treatment language | Any disease treatment or cure claims |
| Trained harvest providers | Provider training documentation and licensure | Unlicensed provider, non-clinical setting |
| Viability certification | Will I receive a written viability certificate? | No viability documentation provided |
| Transparent pricing | Full written price breakdown before signing | Undisclosed fees, bundled treatment packages |
| Storage terms and cell ownership | Written contractual terms on ownership and continuity | No clear ownership language, no continuity provisions |
| Chain of custody | Documentation at each stage from harvest to storage | No chain-of-custody documentation |
The table distills the seven criteria into a single-page reference that patients can use during any banking consultation. The foundational Zuk 2002 paper and the 21 CFR Part 1271 framework together provide the scientific and regulatory basis for each criterion, and the red flags listed in the third column are direct signals that a service may not be meeting the corresponding standard.
Red Flags That Should End a Conversation Immediately
Three things should immediately disqualify any banking service, regardless of how compelling the marketing is.
- Treatment claims. Any claim that banking will treat, cure, or prevent a specific disease or condition. A compliant banking service does not make these claims because banking is preservation, not treatment, and a service that cannot or will not distinguish the two is operating outside the regulatory framework that makes banking a legitimate option in the first place.
- Unregistered laboratory. A processing laboratory that cannot be verified on the FDA’s tissue establishment registry is not operating under the required regulatory framework. There is no compliant substitute for FDA registration, and a service that cannot produce FDA registration documentation for its processing partner is disqualifying on that basis alone.
- Bundled therapeutic injections. Any package that bundles banking with immediate stem cell injections or “treatment sessions” is combining a compliant banking service with an unapproved therapeutic claim. These are separate services with fundamentally different regulatory statuses, and their bundling is a red flag for the entire offering because it signals that the service is willing to blur the regulatory line in ways that compliant banking services do not.
The FDA’s tissue products page and the 21 CFR Part 1271 framework together establish why each of the three red flags is disqualifying, and Save My Fat’s resource on fake stem cell clinic red flags covers the broader pattern of predatory marketing that patients should watch for when evaluating any cellular-therapy-adjacent service.
Questions to Ask Any Banking Service Before Committing
Bring this question list to any consultation or sales conversation with a banking service.
- What is the name of your processing laboratory, and is it FDA-registered under 21 CFR Part 1271?
- What training did the physician performing my harvest complete for this specific protocol?
- Will I receive a written viability certificate after processing, and what specific data does it include?
- What is the complete pricing, including annual storage fees and any vial release or shipping fees?
- Who owns my banked cells contractually, and what are the storage continuity protections if the service or laboratory closes?
- What chain-of-custody documentation will I receive from harvest to storage?
- Does your service make any claims about treating or curing diseases with banked cells?
If any of these questions receive an evasive or unsatisfactory answer, that is important information about the service. The questions themselves are not adversarial. They are the standard due diligence any informed patient should apply to a significant cash-pay health investment, and a compliant banking service should be able to answer each of them clearly and specifically. Save My Fat’s resources on questions to ask before banking and informed consent in regenerative medicine cover the due diligence framework in more depth.
Key Takeaways
Seven criteria apply to any banking service evaluation. FDA-registered processing laboratory. No treatment claims. Trained and licensed harvest providers. Viability certification documenting specific cell yield and quality. Transparent pricing with full written itemization. Clear storage terms and cell ownership. Documented chain of custody from harvest through long-term storage. Each of the seven is verifiable through specific questions, and each corresponds to a specific element of the Section 361 HCT/P regulatory framework that governs compliant banking.
Three immediate disqualifiers should end any evaluation conversation without proceeding further. Treatment claims that blur the line between banking and therapy. An unregistered laboratory that cannot be verified on the FDA tissue establishment registry. Bundled packages that combine banking with unapproved therapeutic injections, which signals that the service is willing to blur the regulatory framework in ways that compliant banking services do not.
Ask all seven evaluation questions before committing to any service, including Save My Fat. The framework is intentionally general so it applies equally across providers, and a service that can answer all seven questions clearly and specifically is demonstrating the operational transparency that the investment deserves.
The evaluation framework is more protective than any single provider’s marketing. A service that cannot answer these questions clearly is not worth your investment regardless of how compelling the rest of the presentation has been, and a service that can answer all seven is demonstrating the compliance and transparency that makes banking a legitimate option in the first place.
Save My Fat’s structural features map directly onto all seven criteria. L2 Bio is an FDA-registered tissue establishment. No treatment claims are made. All partner providers are trained licensed physicians operating in clinical settings. Every patient receives a viability certificate. Pricing is published and itemized. Ownership and continuity terms are documented in the patient agreement. Chain-of-custody documentation is generated at each stage of the process. These are features of the program’s operational structure rather than marketing claims, and each can be verified through the documentation the service provides before and after banking.
Ready to Evaluate Save My Fat Directly?
Before moving forward with any banking service: adipose tissue banking is a preservation service for potential future use in FDA-regulated pathways, not a treatment or a guarantee of access to any specific clinical trial, therapy, or product. No adipose-derived product is FDA-approved for general disease treatment, and banking cannot be represented as a treatment for any condition. The evaluation framework in this post applies equally to Save My Fat and to any other banking service, and patients are encouraged to apply it rigorously before committing to any provider. Physicians considering partnership should independently verify applicable state licensing and informed-consent requirements, particularly in Florida, Utah, and Nevada, which have stem cell-specific statutes.
To review the partner provider network, visit the provider program overview. To compare banking services across the evaluation framework covered in this post, visit the Save My Fat resource on how to compare banking services. To review current pricing, visit savemyfat.com/pricing. To prepare your evaluation questions for any consultation, visit the resource on questions to ask before banking.
Save My Fat provides adipose tissue banking services in partnership with L2 Bio for laboratory operations. Save My Fat does not provide medical treatments, clinical trial enrollment, or Expanded Access services.
This article is for educational purposes only and does not constitute medical or legal advice. Legal and medical review including neurology and neurosurgery input is required before publication. Please consult your neurologist or neurosurgeon before making any decisions about neurologic treatment or research participation.
